ACQUIRED · 2022
Who Acquired Aran Biomedical and Proxy Biomedical?
Integer Holdings Corp. · $131.0M
The acquisition
Aran Biomedical and Proxy Biomedical was acquired by Integer Holdings Corp. in 2022 for $131.0M. at 7.70× revenue.
Aran Biomedical and Proxy Biomedical at time of acquisition
Revenue
$17.0M
Deal value
$131.0M
Other acquisitions by Integer Holdings Corp.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Precision Coating · 2025 · $153.5M
- Vertical Solutions, Inc., d/b/a VSi Parylene · 2025 · $24.0M
- Oscor Inc. · 2021 · $215.2M
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2022). Aran Biomedical and Proxy Biomedical acquired by Integer Holdings Corp.. https://exitvalue.ai/acquired/aran-biomedical-and-proxy-biomedical